The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial
- DOI
- 10.1186/s13054-023-04719-9
- Published
- 2023-11-09
- Container
- Critical Care
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13054-023-04719-9,
title = {The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial},
author = {Mervyn Singer and Antoni Torres and Corina C. Heinz and Sabrina Weißmüller and Alexander Staus and Steffen Kistner and Ksenia Jakubczyk and Thomas Häder and Patrick Langohr and Andrea Wartenberg-Demand and Jörg Schüttrumpf and Jean-Louis Vincent and Tobias Welte},
year = {2023},
journal = {Critical Care},
doi = {10.1186/s13054-023-04719-9},
url = {https://doi.org/10.1186/s13054-023-04719-9}
}RIS
TY - JOUR TI - The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial AU - Mervyn Singer AU - Antoni Torres AU - Corina C. Heinz AU - Sabrina Weißmüller AU - Alexander Staus AU - Steffen Kistner AU - Ksenia Jakubczyk AU - Thomas Häder AU - Patrick Langohr AU - Andrea Wartenberg-Demand AU - Jörg Schüttrumpf AU - Jean-Louis Vincent AU - Tobias Welte PY - 2023 JO - Critical Care DO - 10.1186/s13054-023-04719-9 UR - https://doi.org/10.1186/s13054-023-04719-9 ER -
APA
Singer, M., Torres, A., Heinz, C. C., Weißmüller, S., Staus, A., Kistner, S., Jakubczyk, K., Häder, T., Langohr, P., Wartenberg-Demand, A., Schüttrumpf, J., Vincent, J., & Welte, T. (2023). The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial. Critical Care. https://doi.org/10.1186/s13054-023-04719-9
Source records
- crossref · retrieved 2026-09-26T15:00:49.252Z